×
About 2,848 results

ALLMedicine™ Varicella-zoster Center

Research & Reviews  968 results

Overlapping Signs and Symptoms Between Recurrent Varicella and Pityriasis Rosea Gibert.
https://doi.org/10.1097/INF.0000000000003601
The Pediatric Infectious Disease Journal; Baba K, Baba T et. al.

Jun 29th, 2022 - Pityriasis rosea Gibert (PRG) has features similar to those of common infectious childhood diseases, suggesting a viral cause, but no agent has been identified to date. We describe 4 children with PRG and 2 with recurrent varicella who were studie...

Early Symptomatic HIV Infection
http://emedicine.medscape.com/article/211873-overview

Jun 27th, 2022 - Overview Early symptomatic human immunodeficiency virus (HIV) infection includes persistent generalized lymphadenopathy, often the earliest symptom of primary HIV infection; oral lesions such as thrush and oral hairy leukoplakia; hematologic distu...

Vaccine-Strain Varicella Virus Transmitted to a Term Infant Following Maternal Postpart...
https://doi.org/10.1093/jpids/piac050
Journal of the Pediatric Infectious Diseases Society; Saringkarisate K, Len KA et. al.

Jun 26th, 2022 - Varicella is a highly contagious disease caused by Varicella-zoster virus (VZV). The American College of Obstetricians and Gynecologists (ACOG) adopted the routine administration of varicella vaccine to varicella non-immune mothers postpartum befo...

Evaluate the Safety and Immunogenicity After MG1111 as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st SUDUVAX Inj. Vaccination
https://clinicaltrials.gov/ct2/show/NCT05422508

Jun 16th, 2022 - Safety Incidence of fever (temperature ≥39.0℃) within 42 days after the IP administration Incidence of fever (temperature ≥39.0℃) within 7 days after the IP administration Solicited local/systemic AEs occurred within 7 days after the IP administra...

Incident Herpes Zoster and Risk of Dementia: A Population-Based Danish Cohort Study.
https://doi.org/10.1212/WNL.0000000000200709
Neurology Johannesdottir Schmidt SA, Veres K et. al.

Jun 9th, 2022 - Herpes zoster is caused by reactivation of the neurotrophic varicella-zoster virus. Zoster may contribute to development of dementia through neuroinflammation, cerebral vasculopathy, or direct neural damage, but epidemiological evidence is limited...

see more →

Guidelines  1 results

Updated recommendations for use of VariZIG--United States, 2013.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604813
MMWR. Morbidity and Mortality Weekly Report;

Jul 19th, 2013 - In December 2012, the Food and Drug Administration (FDA) approved VariZIG, a varicella zoster immune globulin preparation (Cangene Corporation, Winnipeg, Canada) for use in the United States for postexposure prophylaxis of varicella for persons at...

see more →

Drugs  11 results see all →

Clinicaltrials.gov  47 results

Evaluate the Safety and Immunogenicity After MG1111 as 2nd Vaccination in 4 ~ 6 Year Old Healthy Children With a History of 1st SUDUVAX Inj. Vaccination
https://clinicaltrials.gov/ct2/show/NCT05422508

Jun 16th, 2022 - Safety Incidence of fever (temperature ≥39.0℃) within 42 days after the IP administration Incidence of fever (temperature ≥39.0℃) within 7 days after the IP administration Solicited local/systemic AEs occurred within 7 days after the IP administra...

Intralesional Vitamin D3 Versus Intralesional Acyclovir in Treatment of Plantar Warts
https://clinicaltrials.gov/ct2/show/NCT05324904

Apr 13th, 2022 - Introduction Warts are common epidermal growths caused by various strains of human papillomavirus (HPV) affecting all age groups. They have an unsightly appearance and are mostly asymptomatic but sometimes may be painful as in the case of palmopla...

Combined Application of Pulsed RF and Steroids to the DRG for PHN
https://clinicaltrials.gov/ct2/show/NCT05208918

Jan 26th, 2022 - Varicella-zoster virus reactivates in sensory ganglia as the dorsal root ganglion (DRG). The DRG contains many receptor channels and is an important region for pain signal transduction. Sustained abnormal electrical activity to the spinal cord via...

Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
https://clinicaltrials.gov/ct2/show/NCT05198570

Jan 20th, 2022 - Herpesvirus infections may lead to severe disease with a high risk of complications and mortality in hematopoietic stem cell transplant (HSCT) recipients, or in patients receiving high-intensity chemotherapy for hematological malignancies. That ri...

Study on Efficacy of Attenuated Zoster Vaccine, Live
https://clinicaltrials.gov/ct2/show/NCT04334577

Dec 8th, 2021 - Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clinical syndromes. Primary infection is manifested as varicella (chickenpox) , whereas reactivation of latent VZV results in a localized eruption known as herpes zoster. The i...

see more →

News  106 results

Surprising Link Between Herpes Zoster and Dementia
https://www.medscape.com/viewarticle/975400

Jun 10th, 2022 - Herpes zoster does not appear to increase dementia risk ― on the contrary, the viral infection may offer some protection, a large population-based study suggests. "We were surprised by these results [and] the reasons for the decreased risk are unc...

Cutaneous Lupus Erythematosus–like Isotopic Response to Herpes Zoster Infection
https://www.mdedge.com/dermatology/article/254893/infectious-diseases/cutaneous-lupus-erythematosus-isotopic-response
Christen Botros Samaan, MD, Bethany R. Rohr, MD et. al.

May 24th, 2022 - To the Editor: Wolf isotopic response describes the development of a skin disorder at the site of another healed and unrelated skin disease. Skin disorders presenting as isotopic responses have included inflammatory, malignant, granulomatous, and.

Moderna to Develop mRNA-Based Shingles Vaccine
https://www.medscape.com/viewarticle/968850

Feb 22nd, 2022 - (Reuters) - Moderna Inc said on Friday it is developing three new vaccines based on the same technology used for its COVID-19 shot, including one for viral infection shingles. The success of COVID-19 vaccines based on messenger RNA (mRNA) technolo...

Pfizer, BioNTech to Develop Shingles Shot, After COVID-19 Vaccine Success
https://www.medscape.com/viewarticle/966073

Jan 6th, 2022 - (Reuters) - Pfizer Inc and Germany's BioNTech SE will develop an mRNA-based vaccine for the prevention of viral infection shingles, collaborating for the third time after the success of their COVID-19 vaccine based on the same technology. Pfizer p...

Atopic Dermatitis and the Risk of Infections
https://www.medscape.com/viewarticle/962913

Nov 14th, 2021 - Takeaway Atopic dermatitis (AD) was associated with an increased risk of hospitalised infections, opportunistic infections and several herpesvirus infections in both children and adults, with the risk being greatest in those with severe skin disea...

see more →

Patient Education  6 results see all →